Abstract
The role of family history to the risk of breast cancer was analyzed by incorporating menopausal status in Hong Kong Chinese women, with a particular respect to the estrogen receptor-positive (ER+) type. Seven hundred and forty seven breast cancer incident cases and 781 hospital controls who had completed information on family cancer history in first-degree relatives (nature father, mother, and siblings) were recruited. Odds ratio for breast cancer were calculated by unconditional multiple logistic regression, stratified by menopausal status (a surrogate of endogenous female sex hormone level and age) and type of relative affected with the disease. Further subgroup analysis by tumor type according to ER status was investigated. Altogether 52 (6.96%) breast cancer cases and 23 (2.95%) controls was found that the patients' one or more first-degree relatives had a history of breast cancer, showing an adjusted odds ratio (OR) of 2.41 (95%CI: 1.45-4.02). An excess risk of breast cancer was restricted to the ER+ tumor (OR = 2.43, 95% CI: 1.38-4.28), with a relatively higher risk associated with an affected mother (OR = 3.97, 95%CI: 1.46-10.79) than an affected sister (OR = 2.06, 95%CI: 1.07-3.97), while the relative risk was more pro...Continue Reading
References
Nov 1, 1992·American Journal of Epidemiology·J L Hopper, J B Carlin
May 1, 1992·American Journal of Epidemiology·S WacholderJ S Mandel
Dec 20, 1989·Journal of the National Cancer Institute·M H GailJ J Mulvihill
Oct 15, 1988·International Journal of Cancer. Journal International Du Cancer·S C TaoK W Xiu
Feb 1, 1988·Neurology·J C BreitnerK L Davis
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·B NewmanM C King
Nov 1, 1985·American Journal of Epidemiology·P BruzziC Schairer
May 29, 1997·International Journal of Cancer. Journal International Du Cancer·P D PharoahB A Ponder
Feb 26, 2000·Carcinogenesis·B E Henderson, H S Feigelson
Jul 13, 2000·The New England Journal of Medicine·P LichtensteinK Hemminki
May 1, 2001·Nature Medicine·K L NathansonK N Nathanson
Nov 14, 2001·Lancet·UNKNOWN Collaborative Group on Hormonal Factors in Breast Cancer
Aug 15, 2002·British Journal of Cancer·T M MackE B Rappaport
Nov 16, 2002·British Journal of Cancer·G M LeungC-M Wong
Dec 15, 2004·Cancer·Gabriel M LeungTai-Hing Lam
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Steven R CummingsJane A Cauleys
Sep 28, 2005·Cancer Detection and Prevention·Jennifer A RusieckiTongzhang Zheng
Jul 25, 2006·Breast Cancer Research : BCR·Huiyan MaGiske Ursin
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·B A J PonderP D P Pharoah
May 29, 2007·Nature Genetics·Simon N StaceyKari Stefansson
Apr 26, 2008·PLoS Genetics·Montserrat Garcia-ClosasPaul D Pharoah
Apr 29, 2008·Nature Genetics·Simon N StaceyKari Stefansson
Jun 26, 2008·Cancer Causes & Control : CCC·Briseis A KilfoyWei Zheng
Mar 23, 2010·Journal of Clinical Epidemiology·Binod NeupaneMark Loeb
Mar 23, 2010·Journal of the National Cancer Institute·Jonine L BernsteinUNKNOWN WECARE Study Collaborative Group
Nov 23, 2013·Breast Cancer Research and Treatment·Wei ChenXiaoping Miao
Jul 11, 2014·Breast Cancer Research and Treatment·Bo ZhangZhen-dong Chen